Drugs targeting MMP2 have been used for the treatment of cancer (marimastat), renovascular hypertension, and congestive heart failure (captopril), or investigated in clinical trials for the treatment of lung cancer (oleandrin). The gene discussed is MMP2; the disease is lung cancer.